Clinical Trial

Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease

Study acronym: POWER-PD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's Disease (PD) is a complex neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons, which results in a range of motor symptoms such as tremor, rigidity, and bradykinesia, as well as non-motor symptoms including anxiety, depression, and cognitive decline. Strength training has emerged as a promising intervention to improve motor function and influence biochemical markers associated with oxidative stress and neurodegeneration. This study aims to evaluate the effectiveness of a structured strength training protocol over 12 weeks in improving both functional and biochemical outcomes in patients with PD.
Trial Details
NCT Number NCT07095400
Lead Sponsor Universidad Villanueva
Conditions Parkinson Disease
Enrollment 22 participants
Start Date 2025-09-07
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-31